FARMINGDALE, N.Y., Sept. 9 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, two year, sales agency agreement with privately-held Novotech Solutions ("Novotech"), based in Bangalore, India. Novotech will serve as the sales and distribution organization for the SonaStar(R) Ultrasonic Surgical Aspiration System, the BoneScalpel(TM) Ultrasonic Bone Cutting System and the SonicOne(R) Ultrasound Cleansing & Debridement System.
Novotech has extensive experience with a wide variety of medical devices, laboratory instrumentation, and radiopharmaceuticals. The agreement provides Novotech with the rights to sell in most Middle Eastern countries, all North African countries, India, Pakistan and certain other Asian countries. Sales will be consummated primarily through specialty distributors; however, in certain instances, direct to hospital sales will be permitted. Minimum sales performance criteria are stipulated in the agreement.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt(TM) bone shaving technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the potential hazards associated with rotary sharps.
The SonicOne is an innovative, ult
|SOURCE Misonix, Inc.|
Copyright©2009 PR Newswire.
All rights reserved